Skip to main content
. 2015 Apr 11;10(3):10. doi: 10.1007/s12263-015-0461-7

Table 1.

Pathway analysis (summarized)

Pathway # genes % p value Genesa
Cell cycle/checkpoint control 16 4.3 1.1E−16 ATR, BUB1B, CDC45, CDK2, KIF11, MCM2, MCM3, MSH2, MSH6, ORC1, PCNA, PRIM2, RCC2, TMPO, VRK1, WEE1
Cytoskeletal signalling 13 3.2 7.7E−11 ACTG2, DES, GNB2L1, LMNB1, MST4, MYH10, PFN1, PPP1R12A, RCC2, ROCK1, STMN1, TMPO, VAV1
Lymphocyte signalling 9 2.4 2.8E−09 BCL6, HCK, INPP5D, LCP1, MECOM, NQO1, PLCG2, PSIP1, SPI1
Cell cycle_Role of APC in cell cycle regulation 7 1.9 3.3E−09 BUB1, BUB1B, CCNB2, CDC27, CDK2, FBXO5, ORC1
Cell cycle_Transition and termination of DNA replication 6 1.6 1.4E−08 CDK2, LIG1, MCM2, PCNA, PRIM2, RFC3
Immune response_BCR pathway 7 1.9 3.1E−08 BCL6, CD79B, CR2, INPP5D, PIK3R1, PLCG2, VAV1
Chemokine signalling pathway (GeneDecks-KEGG) 8 2.1 2.7E−07 CCL28, CXCL13, CXCR4, HCK, PIK3R1, ROCK1, TIAM1, VAV1
Leucocyte transendothelial migration (GeneDecks-KEGG) 6 1.6 1.6E−06 CDH5, CXCR4, PIK3R1, PLCG2, ROCK1, VAV1
Focal adhesion (GeneDecks-KEGG) 7 1.9 3.2E−06 CAPN2, COL1A1, COL3A1, PIK3R1, PPP1R12A, ROCK1, VAV1
NFKB signalling Targets 5 1.3 8.2E−06 AGT, CD40, CFB, LTB, NQO1
hsa03030:DNA replication 6 1.7 1.7E−03 RFC3, LIG1, PRIM2, PCNA, MCM2, MCM3
hsa03430:Mismatch repair 5 1.4 2.1E−03 MSH6, RFC3, MSH2, LIG1, PCNA
hsa04662:B cell receptor signalling pathway 7 1.9 9.9E−03 CR2, PLCG2, PIK3AP1, CD79B, INPP5D, VAV1, PIK3R1
hsa00230:Purine metabolism 8 2.2 8.2E−02 ENPP3, RRM2, AK1, PRIM2, GUCY1B3, RRM2B, PAPSS2, ADA
hsa04666:Fc gamma R-mediated phagocytosis 8 1.9 2.9E−02 ACTG2, HCK, PLCG2, PIKFYVE, ARPC4, INPP5D, VAV1, PIK3R1
hsa04672:Intestinal immune network for IgA production 5 1.4 3.1E−02 CXCR4, TNFRSF17, PIGR, CD40, CCL28
hsa04115:p53 signalling pathway 5 1.4 8.5E−02 CCNB2, RRM2, RRM2B, ATR, CDK2
hsa03320:PPAR signalling pathway 5 1.4 8.9E−02 HMGCS2, APOC3, PPARG, FABP2, MMP1

DAVID pathways (hsa) with a p value of <0.1 (EASE score) and GeneDecks pathways with a p value of <0.05 were retrieved. The complete list of pathways is listed in supplementary Table S2. Official gene symbols are presented. Down-regulated genes are underlined and shown in bold